These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12557230)

  • 1. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
    Chu LW; Troncoso P; Johnston DA; Liang JC
    Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization.
    Fukasawa S; Kino M; Kobayashi M; Suzuki H; Komiya A; Imamoto T; Hirokawa Y; Shiraishi T; Takiguchi M; Ishida H; Shindo T; Seki N; Ichikawa T
    Prostate Cancer Prostatic Dis; 2008; 11(3):303-10. PubMed ID: 17923855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
    Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
    Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical dissection of genetic pathways involved in prostate carcinogenesis.
    Ribeiro FR; Diep CB; Jerónimo C; Henrique R; Lopes C; Eknaes M; Lingjaerde OC; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2006 Feb; 45(2):154-63. PubMed ID: 16235241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization.
    Wolter H; Gottfried HW; Mattfeldt T
    BJU Int; 2002 Feb; 89(3):310-6. PubMed ID: 11856117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T
    Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization.
    Kasahara K; Taguchi T; Yamasaki I; Kamada M; Shuin T
    Cancer Genet Cytogenet; 2005 May; 159(1):84-8. PubMed ID: 15860364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
    Partheen K; Levan K; Osterberg L; Helou K; Horvath G
    Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
    Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
    Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma.
    Liu XP; Kawauchi S; Oga A; Sato T; Ikemoto K; Ikeda E; Sasaki K
    Oncol Rep; 2007 Jan; 17(1):261-7. PubMed ID: 17143507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.
    Sun J; Liu W; Adams TS; Sun J; Li X; Turner AR; Chang B; Kim JW; Zheng SL; Isaacs WB; Xu J
    Prostate; 2007 May; 67(7):692-700. PubMed ID: 17342750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
    Bubendorf L
    Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization.
    Chu LW; Pettaway CA; Liang JC
    Cancer Genet Cytogenet; 2001 Jun; 127(2):161-7. PubMed ID: 11425457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization in primary sinonasal adenocarcinomas.
    Ariza M; Llorente JL; Alvarez-Marcas C; Baragaño L; Salas A; Rodriguez Prado N; Hermsen M; Suárez C; Sampedro A
    Cancer; 2004 Jan; 100(2):335-41. PubMed ID: 14716769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.